APA

Rosse R. B., Kendrick K., Fay-McCarthy M., Prell G. D., Rosenberg P., Tsui L. C., Wyatt R. J. & Deutsch S. I. (19961206). An open-label study of the therapeutic efficacy of high-dose famotidine adjuvant pharmacotherapy in schizophrenia: preliminary evidence for treatment efficacy. : Clinical neuropharmacology.

Chicago

Rosse R B, Kendrick K, Fay-McCarthy M, Prell G D, Rosenberg P, Tsui L C, Wyatt R J and Deutsch S I. 19961206. An open-label study of the therapeutic efficacy of high-dose famotidine adjuvant pharmacotherapy in schizophrenia: preliminary evidence for treatment efficacy. : Clinical neuropharmacology.

Harvard

Rosse R. B., Kendrick K., Fay-McCarthy M., Prell G. D., Rosenberg P., Tsui L. C., Wyatt R. J. and Deutsch S. I. (19961206). An open-label study of the therapeutic efficacy of high-dose famotidine adjuvant pharmacotherapy in schizophrenia: preliminary evidence for treatment efficacy. : Clinical neuropharmacology.

MLA

Rosse R B, Kendrick K, Fay-McCarthy M, Prell G D, Rosenberg P, Tsui L C, Wyatt R J and Deutsch S I. An open-label study of the therapeutic efficacy of high-dose famotidine adjuvant pharmacotherapy in schizophrenia: preliminary evidence for treatment efficacy. : Clinical neuropharmacology. 19961206.